A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch the disease.

A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

She considers herself lucky. She happened to find a doctor who immediately did a biopsy and sent her sample to a lab that likely didn’t have much else to investigate during the pandemic. Whoever her pathologist was, they knew exactly what her illness looked like under a microscope.

Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word. Others disagree.

USC biomedical engineers have found a way to make a solid tumor paint a target on its own back in order to train the body's immune system to find and destroy it.